Moody’s maintains for-profit hospitals’ stable outlook

http://www.healthcaredive.com/news/moodys-maintains-for-profit-hospitals-stable-outlook/505680/

Image result for hospital credit ratings

Dive Brief:

  • Moody’s Investors Service announced in a recently released report that the outlook for U.S. for-profit hospitals is stable.
  • Outpatient services will drive revenue growth. Moody’s said outpatient service growth will result in EBITDA growth of 2.5-3% for for-profit hospitals over the next 18 months. That growth will be offset somewhat by higher patient costs and more uninsured Americans, which may lead to more bad debt for hospitals.
  • Moody’s warned that recent hurricanes in Florida and Texas, which are the two largest states by revenue among for-profit hospitals, may cause short-term financial issues, but Moody’s expects those hospitals will recover quickly.

Dive Insight:

Payers, both private and public, continue to squeeze hospital margins as they push patients to outpatient services. Moody’s said volumes to lower-cost settings will continue. Revenue growth from outpatient services will rise faster than inpatient services.

Moody’s said patients with high-deductible health plans, who pay more out-of-pocket costs, are going to seek less costly settings than hospitals to save money. Also, the CMS’ proposal to allow several orthopedic procedures on an outpatient basis could cause more financial harm for hospitals. “If finalized, this will further push surgeries out of the inpatient setting.”

For-profit hospitals will capture some of the added outpatient volume through their own outpatient departments and associated ambulatory surgery centers. However, some volume will go to competitors, Moody’s warned.

Moody’s expects payer rates will rise, but lower than usual — 1.5-2% net revenue per adjusted admission over the next 18 months. Some factors that will affect the slower growth include the CMS changing disproportionate share payments and proposing 1.75% rates for hospital outpatient procedures, and private payers implementing cost-controlling policies. These policies include Anthem’s plan to no longer pay for MRIs and CTs scans in hospital outpatient departments. Instead, patients will need to get the services at lower-cost, freestanding imaging centers.

Moody’s also warned that rising bad debt and expenses are pressuring margins.

“Higher patient responsibility and fewer insured patients will lead to lower volumes, but also higher costs of uncompensated care. Even with strong cost controls, given the high fixed costs of operating hospitals, it will be difficult to expand margins in an environment of weak patient volumes and rising bad debt expense. At the same time, nursing shortages and rising fees associated with medical specialists (including outsourced emergency departments) will also pressure margins,” said Moody’s.

However, some for-profit systems may see improved margins in the coming months. Moody’s said Quorum Health and Community Health Systems (CHS) will benefit from shedding less profitable facilities, while LifePoint Health and HCA Healthcare will improve margins over time as they improve efficiencies at recently acquired facilities.

Moody’s also warned that Hurricanes Harvey and Irma, which destroyed portions of Texas and Florida, will affect the largest for-profit hospitals: HCA Healthcare, Tenet Healthcare and CHS, which all have “significant presence” in those areas. For those states, Moody’s expects “incremental expenses,” such as cleanup and remediation, staffing and overtime, as well as transporting critically ill patients to other facilities, will play a financial role for those systems in the next two quarters.

Paladin to buy 2 Tenet hospitals for $170M

http://www.beckershospitalreview.com/hospital-transactions-and-valuation/paladin-to-buy-2-tenet-hospitals-for-170m.html

Image result for paladin healthcare

Dallas-based Tenet Healthcare will sell its two Philadelphia hospitals to El Segundo, Calif.-based Paladin Healthcare for $170 million, to help lighten its debt burden of $15 billion.

The sale will transfer ownership of Hahnemann University Hospital, St. Christopher’s Hospital for Children and other related operations in Philadelphia to American Academic Health System, a new company formed by Paladin Healthcare.

“Paladin shares [Tenet’s] commitment to providing compassionate, exemplary care and service, and we believe that entrusting the stewardship of these institutions to its affiliate AAHS will benefit the patients, employees, physicians and community for years to come,” said Mike Halter, CEO for Tenet’s Philadelphia division and CEO of Hahnemann University Hospital.

The transaction is expected to be completed in early 2018. It will need regulatory approval.

The decision to sell the two hospitals comes a day after Tenet announced it would replace longtime CEO Trevor Fetter and “refresh” the composition of its board of directors.

Despite jitters, some health insurers start to prosper

http://www.tampabay.com/news/business/1-inch-1-inch-of-body-type-1-inch-1-inch-of/2335280

Image result for health insurance company profits

 

It has not been a market for the faint of heart.

Supporters of the Affordable Care Act achieved a major victory this past week when, thanks to cajoling and arm-twisting by state regulators, the last “bare” county in the United States — in rural Ohio — found an insurer willing to sell health coverage through the law’s marketplace there. So despite earlier indications that insurance companies would stop offering coverage under the law in large parts of the country, insurers have now agreed to sell policies everywhere.

But a moment of truth still looms for the industry in the coming weeks under the law known as Obamacare. Companies must set their final plans and premiums by late September, even as the Trump administration continues to threaten to cut off billions of dollars in government subsidies promised by the legislation. Insurers are also awaiting Senate hearings set to start Sept. 6 for a hint of what steps, if any, lawmakers may take to stabilize the market.

With congressional Republicans’ yearslong quest to dismantle the Affordable Care Act dead for now, the fate of the landmark law depends in large part on the health of the insurance marketplaces and the ability of insurers to make a viable business out of selling coverage to individuals. When the law passed seven years ago, insurers saw a potential bonanza: tens of millions of brand-new paying customers, many backed by generous government subsidies and required by the new law to have health coverage. Now, about four years after the law’s marketplaces opened for business, most of the industry’s biggest players have pulled out.

Yet the continuing churn among insurers and the anxiety pervading the industry have obscured an encouraging fact: Many of the remaining companies have sharply narrowed their losses, analysts say, and some are even beginning to prosper.

“Outside of the noise,” the surviving companies “are seeing a path forward in this marketplace,” said Deep Banerjee, an analyst with Standard & Poor’s who has examined the financial results of more than two dozen Blue Cross insurers.

“It is still a new market,” he added, “and everyone is adjusting to it.”

The healthier business outlook has been achieved at a big cost to consumers. To stanch their losses, many companies raised their prices substantially for this year while narrowing their networks of providers to hold down costs.

In some cases, companies will seek even higher rates for 2018; the lone insurer left in Iowa is asking for a nearly 60 percent increase, on average.

Among the insurers now making money in the individual market and expanding is Centene, a for-profit company. Some of the Blue Cross insurers, including Health Care Service Corp., which operates plans in multiple states, including Texas and Illinois, and Independence Blue Cross, which has 300,000 customers in Pennsylvania and New Jersey, began to turn a profit in the market this year.

Oscar Health, a venture capital-backed insurance startup, lost roughly $200 million last year but, sensing a more promising future, plans to enter three more states and expand in California and Texas.

Centene made use of its experience, including setting up networks of hospitals and doctors that care for Medicaid patients, to sell coverage. The company now insures about 1.1 million people in the individual market.

“For 2018, we intend to grow this profitable segment of our business,” Michael Neidorff, the company’s chief executive, told investors last month.

Hospital stocks sink after HCA’s earnings stumble

http://www.beckershospitalreview.com/finance/hospital-stocks-sink-after-hca-s-earnings-stumble.html

Image result for hca

Major for-profit hospital operators saw their share prices fall Tuesday after Nashville, Tenn.-based HCA Healthcare released its earnings for the second quarter, which fell below analysts’ estimates, according to Bloomberg.

HCA’s revenues increased 4 percent year over year to $10.73 billion in the second quarter of 2017, which fell below analysts’ estimate of $10.85 billion. The company ended the second quarter of this year with net income of $657 million, which was down slightly from $658 million in the same period of 2016.

After releasing its earnings, HCA shares fell 2.5 percent to $83.93. Dallas-based Tenet Healthcare shares dropped 7.3 percent to $19.57 and Franklin, Tenn.-based Community Health Systems shares fell 7.4 percent to $8.96, according to Bloomberg.

Steward Health Care to acquire IASIS Healthcare

http://www.beckershospitalreview.com/hospital-transactions-and-valuation/steward-health-care-to-acquire-iasis-healthcare.html

Related image

Boston-based Steward Health Care has signed a definitive agreement to acquire Franklin, Tenn.-based IASIS Healthcare.

The Wall Street Journal reported the transaction is for $1.9 billion. Becker’s has reached out to Steward to verify the value of the deal and the article will be updated accordingly.

Under the deal, Steward will become the largest private for-profit hospital operator in the U.S. with 36 hospitals across 10 states, managed care operations in Arizona, Utah and Massachusetts and projected revenues of nearly $8 billion in 2018, the first year of consolidated operations. The transaction, which is subject to regulatory approvals and customary closing conditions, is expected to close in the third calendar quarter of 2017, according to a news release on Steward’s website.

Currently, Steward operates 18 hospitals and directly employs more than 1,300 multispecialty physicians in facilities across Massachusetts, Ohio, Florida and Pennsylvania. IASIS operates 17 hospitals and one behavioral health hospital across Utah, Arizona, Colorado, Texas, Arkansas and Louisiana.

The deal will transfer operations of IASIS Healthcare’s 18 hospitals, which encompass nearly 7,500 patient beds and approximately 38,000 employees — including more than 1,800 directly employed multispecialty physicians and several thousands aligned physicians — to Steward Health Care. Steward will also assume operations of IASIS’ 140 outpatient facilities across Arizona, Arkansas, Colorado, Louisiana, Texas and Utah, according to The Wall Street Journal.

Steward Health Care is backed by private-equity firm Ceberus Capital Management LP and real estate investment trust Medical Properties Trust. Under the deal, Medical Properties Trust has agreed to acquire the interests of substantially all of IASIS’ hospital real estate subject to long-term leases and loans with Steward, according to the news release from Steward. The terms of the agreement specify that cash proceeds paid by MPT and other financing sources will be used to retire IASIS’ senior secured term loans and unsecured notes. Remaining cash proceeds will be paid to IASIS equity holders, including its majority stockholder, TPG Capital.

This deal marks the latest in a series of acquisitions for Steward, which in May closed a deal to acquire eight hospitals from Franklin, Tenn.-based Community Health Systems.

For-profit hospital chain Iasis Healthcare backs away from IPO

For-profit hospital chain Iasis Healthcare backs away from IPO

off-switch

Iasis Healthcare, a for-profit chain with 18 hospitals, nearly 150 ambulatory clinics and a health insurance arm, has withdrawn plans for an initial public offering.

Iasis, based in the Nashville suburb of Franklin, Tennessee, quietly announced the cancellation of the IPO in a Dec. 30 filing with the Securities and Exchange Commission. That was the last business day of the year, when investors and news organizations are typically not paying much attention.

The company had announced nearly two years earlier that it would have an IPO worth as much as $100 million. Iasis did not give a reason for the withdrawal.

The healthcare chain reported a pre-tax loss from continuing operations of $117 million for the fiscal year ended Sept. 30, 2016. That compares to operational earnings of $6.8 million during fiscal 2015.

Mylan’s CEO A Villain? Depends On Your Preferred Brand Of Capitalism

http://healthaffairs.org/blog/2016/09/06/mylans-ceo-a-villain-depends-on-your-preferred-brand-of-capitalism/

Image result for capitalism

Different Flavors Of Capitalism

As usual, the answer is a clear “No” and “Yes,” and resolving the question raises much deeper issues than one executive’s personal culpability. The answer depends on what definition of capitalism one deems appropriate. As the European economist André Sapir has noted, there are actually four distinct brands of capitalism in the Western economy, of which the version practiced in the United States and some other Anglo-Saxon countries—sometimes also referred to as “savage capitalism”—is but one.

The clearest version of raw Anglo Saxon capitalism, and one quoted widely to this day, was offered by the late Nobel Laureate economist Milton Friedman in his classic book “Capitalism and Freedom.” There he proposed that the one and only social obligation to society that the CEO of an investor-owned, for-profit company is “to maximize its profits while engaging in ‘open and free competition without deception and fraud.’” (Quoted in Thomas Carson’s “Friedman’s Theory of Corporate Social Responsibility.”) On that view, any corporate action that is legal is ipso facto ethical.

Ms. Bresch can argue that with her aggressive pricing policy on EpiPen she was merely owning up to this doctrine of Anglo-Saxon capitalism. Her board of directors may or may not have known about that policy with regard to this particular product, one of many the company sells. Here Ms. Bresch also can point out that she is in good company in the drug industry. Many drug companies beyond the poster-boys for what is now decried as “price gouging”—Valeant Pharmaceuticals International and Turing Pharmaceuticals—have adopted raw Anglo-Saxon capitalism as the intellectual foundation for their pricing policies by steadily raising prices on long existing drugs, year after year, or even quarter after quarter.

Fitch: Organic volume grows at for-profit hospitals for first time since 2008

http://www.fiercehealthfinance.com/story/fitch-organic-volume-grows-profit-hospitals-first-time-2008/2016-04-21?utm_medium=nl&utm_source=internal&mrkid=959610&mkt_tok=eyJpIjoiWlRFNVlXVXlPR00zT1RoaiIsInQiOiJlXC9pcVgraUViTldUYWZQMnlDUXZ3NzVoN1ZTdlo1VU81OG1lZWhSZ3dvd0xoOG1qQ2Q2UGUweTRCZXptSFZDdmFiZzRrYm9GNzNYK3BtZXJyeEZsSTFCNUJKdGI1THFnR1kyNGJaeTBlbGc9In0%3D

Print

But phenomenon is not expected to last

Moody’s breaks down challenges facing healthcare organizations in 2016

http://www.healthcarefinancenews.com/slideshow/moodys-explores-challenges-facing-healthcare-organizations?mkt_tok=eyJpIjoiTjJZMU5UQXhNVFJsWWpSaSIsInQiOiJidFZ1RUN4NjdcLzdLK3VFQTVIeGdxSnNWZHZxdThQemM5a2RScVoxTGRtVmFYUjZkeTl0Rms1U1J0SFlDeW52WmUrWjcyODFvaFFXZkl6aUZZSFB2TGZcL3Y4a3ZrUVpwaFNOOUdjanhlNWZZPSJ9

 

Tenet Completes the Sale of its Five Atlanta-area Hospitals and Related Operations to WellStar

http://us11.campaign-archive1.com/?u=d610d4deb64a452522c5c8e05&id=28a1367536&e=01f30b7245

Dollars